Pharmacogenomics and Personalized Medicine in Neuropsychiatry

Francis J. McMahon, Thomas R. Insel

Research output: Contribution to journalArticle

Abstract

Despite the need for more effective treatments for psychiatric disorders, development of new medications has stalled. Here we discuss the promise of personalized medicine in developing more efficacious and individualized pharmacotherapies that take into account genetic variation and target groups of patients who share biology, not just symptoms.

Original languageEnglish (US)
Pages (from-to)773-776
Number of pages4
JournalNeuron
Volume74
Issue number5
DOIs
StatePublished - Jun 7 2012
Externally publishedYes

Fingerprint

Neuropsychiatry
Precision Medicine
Pharmacogenetics
Psychiatry
Drug Therapy
Therapeutics

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Pharmacogenomics and Personalized Medicine in Neuropsychiatry. / McMahon, Francis J.; Insel, Thomas R.

In: Neuron, Vol. 74, No. 5, 07.06.2012, p. 773-776.

Research output: Contribution to journalArticle

McMahon, Francis J. ; Insel, Thomas R. / Pharmacogenomics and Personalized Medicine in Neuropsychiatry. In: Neuron. 2012 ; Vol. 74, No. 5. pp. 773-776.
@article{30fccdc90bac4faca678d30ade2fab9d,
title = "Pharmacogenomics and Personalized Medicine in Neuropsychiatry",
abstract = "Despite the need for more effective treatments for psychiatric disorders, development of new medications has stalled. Here we discuss the promise of personalized medicine in developing more efficacious and individualized pharmacotherapies that take into account genetic variation and target groups of patients who share biology, not just symptoms.",
author = "McMahon, {Francis J.} and Insel, {Thomas R.}",
year = "2012",
month = "6",
day = "7",
doi = "10.1016/j.neuron.2012.05.004",
language = "English (US)",
volume = "74",
pages = "773--776",
journal = "Neuron",
issn = "0896-6273",
publisher = "Cell Press",
number = "5",

}

TY - JOUR

T1 - Pharmacogenomics and Personalized Medicine in Neuropsychiatry

AU - McMahon, Francis J.

AU - Insel, Thomas R.

PY - 2012/6/7

Y1 - 2012/6/7

N2 - Despite the need for more effective treatments for psychiatric disorders, development of new medications has stalled. Here we discuss the promise of personalized medicine in developing more efficacious and individualized pharmacotherapies that take into account genetic variation and target groups of patients who share biology, not just symptoms.

AB - Despite the need for more effective treatments for psychiatric disorders, development of new medications has stalled. Here we discuss the promise of personalized medicine in developing more efficacious and individualized pharmacotherapies that take into account genetic variation and target groups of patients who share biology, not just symptoms.

UR - http://www.scopus.com/inward/record.url?scp=84861940981&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861940981&partnerID=8YFLogxK

U2 - 10.1016/j.neuron.2012.05.004

DO - 10.1016/j.neuron.2012.05.004

M3 - Article

C2 - 22681682

AN - SCOPUS:84861940981

VL - 74

SP - 773

EP - 776

JO - Neuron

JF - Neuron

SN - 0896-6273

IS - 5

ER -